NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice

Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran.
Psychopharmacology (Impact Factor: 3.88). 05/2012; 223(3):345-55. DOI: 10.1007/s00213-012-2722-0
Source: PubMed


Previously, we showed that pioglitazone exerts its antidepressant-like effect through peroxisome proliferator-activated receptor gamma receptors and demonstrated the possible involvement of calcium-dependent nitric oxide synthase inhibitors. Based upon the in vitro results, pioglitazone reduces N-methyl-D-aspartate (NMDA)-mediated calcium currents in hippocampal neurons.
In this study, we evaluated the involvement of the NMDA receptor (NMDAR) on the antidepressant-like effect of pioglitazone in the forced swimming test (FST) in mice.
After the assessment of locomotor activity in the open-field test, mice were forced to swim individually and the immobility time of the last 4 min was evaluated. Pioglitazone was administered orally with doses of 5, 10, and 20 mg/kg 4 h before FST. To assess the involvement of NMDARs in the possible antidepressant-like effect of pioglitazone, a selective glutamate receptor agonist, NMDA (75 mg/kg, intraperitoneally [i.p.] or 20 ng/mouse, intracerebroventricularly [i.c.v.]), was administered before pioglitazone (20 mg/kg). To further determine a possible role of NMDARs in this effect, a noncompetitive antagonist of the NMDA, MK-801 (0.05 mg/kg, i.p. or 100 ng/mouse, i.c.v.), was coadministered with pioglitazone (10 mg/kg) 4 h prior to FST.
Pioglitazone (20 mg/kg) administered 4 h prior to FST significantly reduced the immobility time. Coadministration of the noneffective doses of pioglitazone and MK-801 revealed an antidepressant-like effect in FST. Moreover, NMDA significantly reversed the antidepressant-like effect of pioglitazone administered 4 h prior to FST.
The antidepressant-like effect of pioglitazone in the FST is mediated partly through NMDAR signaling. This study provides a new approach for the treatment of depression.

Download full-text


Available from: Mehrak Javadi-Paydar, Nov 17, 2014
1 Follower
73 Reads
  • Source
    • "Each mouse was judged to be immobile when it ceased struggling and remained floating motionless in water, making only those movements necessary to keep its head above water. The duration of immobility was recorded during the last 4 min of the test (Ghasemi et al., 2009; Porsolt et al., 1977; Salehi-Sadaghiani et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2, 4, 6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72hours following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway was performed 30-60 mins before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-L-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders. Copyright © 2015. Published by Elsevier Inc.
    Progress in Neuro-Psychopharmacology and Biological Psychiatry 08/2015; 64. DOI:10.1016/j.pnpbp.2015.08.004 · 3.69 Impact Factor
  • Source
    • "The ambulatory behavior of mice was assessed in the open-field test (Kaster et al. 2005; Salehi-Sadaghiani et al. 2012). The apparatus consisted of a wooden box measuring 40 3 60 3 50 cm. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study described here was to investigate the effects of pulsed ultrasound and gold nanoparticles (AuNPs) on behavioral, inflammatory and oxidative stress parameters in an experimental model of overuse. Wistar rats performed 21 d of exercise on a treadmill at different intensities and were exposed to ultrasound in the presence or absence of AuNPs. The overuse model promoted behavioral changes and increased creatine kinase, superoxide dismutase and glutathione peroxidase activity, as well as the levels of superoxide, nitrotyrosine, nitric oxide, thiobarbituric acid reactive substance, carbonyl, tumor necrosis factor α and interleukin-6. These values were significantly decreased by AuNPs and by AuNPs plus ultrasound. Catalase activity remained unchanged and the glutathione level increased significantly after exposure to AuNPs plus ultrasound. These results suggest a susceptibility to anxiety as well as elevated levels of oxidative stress. However, therapeutic interventions with AuNPs plus ultrasound reduced the production of oxidants and oxidative damage and improved the anti-oxidant defense system.
    Ultrasound in Medicine & Biology 11/2014; 41(1). DOI:10.1016/j.ultrasmedbio.2014.08.020 · 2.21 Impact Factor
  • Source
    • "To ensure that alterations in the duration of immobility were not due to changes in motor activity, the ambulatory behavior of mice was assessed in an open-field test immediately before the FST (Kaster et al., 2005; Salehi-Sadaghiani et al., 2012). The apparatus consisted of a wooden box measuring 40×60×50 cm. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Estradiol decline has been associated with depressive like behavior in female mice and NO has been suggested to play a major role in pathogenesis of major depression. This study was conducted to investigate the antidepressant-like effects of acute estradiol administration in female ovariectomized (OVX) mice and the possible role of nitric oxide (NO)/cyclic GMP (cGMP) pathway. To this end, bilateral ovariectomy was performed in female mice and different doses of estradiol were injected alone or in combination with non-specific NO synthase (NOS) inhibitor (L-NAME), selective neural NOS (nNOS) inhibitor (7NI), an NO precursor (L-Arginine) or selective phosphodiesterase type 5 inhibitor (sildenafil). The duration of immobility was recorded in the forced swimming test (FST) to assess the depressive behavior. Moreover, hippocampal levels of NO were determined in select groups. 10days following the procedure, OVX mice showed significantly prolonged immobility time in comparison with sham group. Estradiol (3, 10, 30μg/kg, s.c.), when injected 1hour prior to FST, exerted antidepressant-like effects in OVX mice. Both L-NAME (30mg/kg, i.p.),and 7-NI (50mg/kg, i.p.) significantly reduced the immobility times of OVX mice. Administration of a sub-effective dose of L-NAME (10mg/kg), 15min after a sub-effective dose of estradiol (1μg/kg, s.c.) had a robust antidepressant-like effect in OVX mice. Also a sub-effective dose of 7-NI (25mg/kg), 30min after after a sub-effective dose of estradiol (1μg/kg, s.c.) showed antidepressant-like effect in OVX mice. Both the NO precursor L-arginine (750mg/kg, i.p.) and the cGMP-specific phosphodiesterase type 5 inhibitor sildenafil (5mg/kg, i.p.), 30min before estradiol treatment, prevented the antidepressant-like effect of a potent dose of estradiol (10μg/kg, s.c.) in OVX mice.The present findings suggest that suppression of the NO synthase/NO/cGMP pathway may be involved in the antidepressant-like effects of estradiol in OVX mice.
    Hormones and Behavior 12/2012; 63(2). DOI:10.1016/j.yhbeh.2012.12.005 · 4.63 Impact Factor
Show more